RATIONALE: Insects are increasingly used as nutrient source for people and animals. As they are considered as ''novel food'', several safety aspects need to be evaluated initially, including the risk of allergenicity. METHODS: IgE from patients allergic to crustaceans, house dust mite (HDM) and/or stable flies was evaluated for cross-recognition of proteins in house cricket Acheta domesticus (AD), desert locust Schistocerca gregaria (SG) and Yellow mealworm Tenebrio molitor (TM). For food processing, different extraction methods, enzymatic hydrolysis, and thermal treatment were applied to migratory locust (Locusta migratoria, LM) extract. Then we proceeded with in vivo testing of crustacean allergic subjects. Crude, enzymatically processed and heat-treated extracts of LM were tested in skin prick test (SPT) in patients with clinical crustacean allergy, first as diluted extracts (1:10 v/v in glycerin 50%) followed by SPT with concentrates. Ditto SPT were performed with centrifuged TM (no enzymes). RESULTS: IgE from patients with crustacean-allergy shows crossrecognition of extracts from AD, SG and stable flies; house dust mite allergics' IgE binds to AD and SG proteins; and the flies-allergic patient recognized AD, SG and LM. Food processing such as enzymatic hydrolysis or heat treatment of LM extract not only completely abolished in vitro-binding of cross-reactive IgE, but also its IgE crosslinking capacity in in vivoskin prick tests. However, centrifugation of TM did not reduce SPT reactivity. CONCLUSIONS: This study provides evidence that enzymatic and thermal processing of insects can reduce the risk of these novel foods to elicit cross-reactivity and allergenicity in crustacean-and HDM-allergic patients.
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Sensitization to Api m 1, Api m 2, and Api m 4 in Japanese beekeepers who had experienced systemic reactions to honeybee stings The major allergen components of honeybee (HB) venom are phospholipase A2 (Api m 1), hyaluronidase (Api m 2), and melittin (Api m 4). IgE antibodies specific(s) to phospholipase A2, hyaluronidase, and melittin bind to recombinant (r)Api m 1, rApi m 2, and rApi m 4, respectively, and show increased test specificity due to the lack of carbohydrate determinants in the recombinant protein. The differences in sensitization due to race or stinging environment and the significance of measuring sIgE to these allergen components are not known. In this study, we analyzed sensitization to Api m 1, Api m 2, and Api m 4 in Japanese beekeepers who had experienced systemic reactions (SRs) to HB stings. METHODS: The participants comprised 121 beekeepers Japan. Of the beekeepers, 34 who had experienced an SR to a HB sting were analyzed in this study. All participants underwent a medical examination including an interview with an allergist and peripheral blood tests were performed on the day of the examination, RESULTS: sIgE positivity to HB venom, rApi m 1, rApi m 2, and sApi m 4 was identified in 32 (94.1%), 31 (91.2%), 33 (97.1%), and 18 (52.9%) beekeepers, respectively. Double positivity to rApi m 1 and rApi m 2 was found in 30 individuals (88.3%). The combination of rApi m 1 and rApi m 2 improved the sensitivity from 94.1% (32/34) to 100% (34/34). CONCLUSIONS: Combination measurement of sIgE to rApi m 1 and rApi m 2 improves the sensitivity for HB venom allergy detection. 
METHODS:
We included all patients who were referred for HVA immunotherapy in a single referral center (Meir Hospital, Israel) . Patients were evaluated for baseline serum tryptase and peripheral-blood c-Kit D816V mutation. Clinical data were obtained from patient medical charts. RESULTS: A total of 153 subjects were enrolled, showing a low median age of 21 yrs, compared to 40-50 yrs in other studies. The most prevalent allergen was bee venom (89%, vs. 20-30% in European reports). Elevated tryptase levels were detected in only 5 subjects (3.3% vs. 10-16% as previously published) and c-Kit D816V mutation was found in 4 individuals (4.4%). Factors associated with severe sting anaphylaxis were advanced age, multiple venom sensitization and tryptase levels. Unlike other studies, the peak incidence of near-fatal reactions to stings was at tryptase values of 5.5-7.0 ng/mL rather than at higher levels. Similar to previous reports, bee venom sensitization was linked to VIT adverse reactions, however, with no correlation to tryptase levels. CONCLUSIONS: This Mediterranean cohort exhibits variations from previously published European studies on HVA patients. Our work underscores population differences suggesting that interpretation of risk factors should be adjusted to specific cohorts.
